In a pooled analysis of clinical trials for HIV-associated aggressive B-cell NHL comparing R-EPOCH (AMC034) to R-CHOP (AMC010), R-EPOCH resulted in superior outcomes compared to R-CHOP 28. The gene discussed is DDIT3; the disease is B-cell non-Hodgkin lymphoma.